Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation

Autor: Mujtaba, M.A. *, Komocsar, W.J., Nantz, E., Samaniego, M.D., Henson, S.L., Hague, J.A., Lobashevsky, A.L., Higgins, N.G., Czader, M., Book, B.K., Anderson, M.D., Pescovitz, M.D., Taber, T.E.
Zdroj: In American Journal of Transplantation April 2016 16(4):1266-1275
Databáze: ScienceDirect
Externí odkaz: